IONS - Ionis Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
587,367
587,000
810,000
729,000
1,123,000
Cost of Revenue
14,116
14,000
11,000
12,000
4,000
Gross Profit
573,251
573,000
799,000
717,000
1,119,000
Operating Expenses
Research Development
833,147
833,000
643,000
535,000
466,000
Selling General and Administrative
150,295
151,000
186,000
354,000
287,000
Total Operating Expenses
983,442
984,000
829,000
889,000
753,000
Operating Income or Loss
-410,191
-411,000
-30,000
-172,000
366,000
Interest Expense
8,122
8,122
4,300
44,990
49,000
Total Other Income/Expenses Net
160,328
153,000
-5,113
2,000
30,000
Income Before Tax
-257,985
-258,000
-30,000
-170,000
347,000
Income Tax Expense
11,737
12,000
-1,000
317,000
44,000
Income from Continuing Operations
-269,722
-270,000
-29,000
-487,000
303,000
Net Income
-269,722
-270,000
-29,000
-451,000
294,000
Net Income available to common shareholders
-269,722
-270,000
-29,000
-451,000
294,000
Basic EPS
-
-1.90
-0.20
-3.18
2.00
Diluted EPS
-
-1.90
-0.20
-3.18
1.90
Basic Average Shares
-
141,848
141,021
139,612
139,998
Diluted Average Shares
-
141,848
141,021
139,612
153,164
EBITDA
-
-411,000
-30,000
-172,000
396,000